Tricyclic antidepressants
Cyclic antidepressants approved to treat depression
Stopping treatment with cyclic antidepressants
Content
How tricyclic antidepressants work
Tricyclic antidepressants approved to treat depression
Possible side effects and cautions
Safety issues
Suicide risk and antidepressants
Stopping treatment with tricyclic antidepressants
Finding the right antidepressant
Tricyclic antidepressants approved to treat depression
The U.S. Food and Drug Administration, also called FDA, approved several tricyclic antidepressants to treat depression. Examples include:
- Amitriptyline.
- Desipramine (Norpramin).
- Doxepin.
- Imipramine.
- Nortriptyline (Pamelor).
- Protriptyline.
Sometimes tricyclic antidepressants are used to treat conditions other than depression. For example, the FDA approved clomipramine (Anafranil) to treat obsessive-compulsive disorder and imipramine to treat childhood bed-wetting. Some tricyclic antidepressants also are used to treat anxiety disorders and nerve-related pain called neuropathic pain and to prevent migraines.
Tricyclic antidepressants are a type of cyclic antidepressant. This type also includes tetracyclic antidepressants. Cyclic antidepressants are grouped depending on the number of rings in their chemical structure — three (tri) or four (tetra). In the United States, currently the FDA does not approve any tetracycline antidepressant to treat depression.